Gut Microbioma in Childhood Health and Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 15645
Special Issue Editors
Interests: molecular mechanisms underlying intestinal inflammation; immuno-pathogenesis of inflammatory bowel diseases; genetics of inflammatory bowel diseases; mucosal healing of inflammatory bowel disease; neuro-gastroenterology and disorders of intestinal motility; immuno-pathogenesis of food allergy; genetics and immuno-pathogenesis of celiac disease
Interests: immunopathogenesis of inflammatory bowel diseases; genetics of inflammatory bowel diseases; mechanisms of interaction between commensal microbiota and innate immune system; analysis of gut microbiota composition and functions through next generation sequencing; novel non-pharmacological therapies for the treatment of inflammatory immune-mediated diseases; inflammatory processes in gut-liver and gut-brain axis
Special Issue Information
Dear Colleagues,
The gut microbiota (GM) composition and function is a major factor involved in human health and disease. In particular, GM is a key player in the mechanisms underlying chronic multifactorial disorders, known as noncommunicable diseases, interacting with host genetics and immune system. In this interplay the intestine has a gatekeeper role, since it harbours a very heterogeneous microbial community and possesses a sophisticated immune system which is daily exposed to a multitude of food and microbial antigens.
The GM is characterized by distinctive compositional and functional features in different periods of life. Emerging evidence suggests that the microbes found in the human body are essential for the development and maturation of the child's immune system; moreover, they play fundamental roles in nutrition and resistance to pathogens at all ages.
The developmental origin of health and disease highlights the importance of the first two years of life of humans and the GM establishment is included in this time window. Microbiota gained at birth develops in parallel as the host matures and maintains its temporal stability and diversity through adulthood. Recent developments in genome sequencing technologies and bioinformatics have allowed to explore the composition and functions of GM at a high level of depth. The collected evidences suggest that though a part of the microbiota is conserved, the dynamic members vary along the gastrointestinal tract from infants to elderly in different health conditions.
Alterations of the GM may lead to the onset of several complex disorders, such as food allergies, inflammatory bowel disease, metabolic disease but also diseases related to the neurodevelopment. Restoring immune homeostasis through the normalization of the GM is now considered a valuable therapeutic approach to treat pediatric patients.
Therefore, manipulating human GM (through different strategies such as probiotics, symbiotics, live biotherapeutics, post-biotics and fecal microbiota transplantation) may represent an innovative and robust strategy for treating and preventing many chronic disorders arising from altered GM development during the pediatric age.
The purpose of this special issue is to provide an overview of the GM role during the childhood in health and disease and the use of the microbiota-directed therapies in pediatric disorders.
Prof. Dr. Salvatore Cucchiara
Prof. Dr. Laura Stronati
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiota
- dysbiosis
- paediatrics
- development
- inflammation